NewAmsterdam Pharma Warrant
NAMSW
11 hedge funds and large institutions have $15.9M invested in NewAmsterdam Pharma Warrant in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 10 closing their positions.
181% more capital invested
Capital invested by funds: $5.65M → $15.9M (+$10.2M)
0.26% less ownership
Funds ownership: 2.01% → 1.74% (-0.26%)
39% less funds holding
Funds holding: 18 → 11 (-7)
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
GTS Securities
Miami,
Florida
|
+$1.1M |
| 2 |
AAA
Affinity Asset Advisors
New York
|
+$597K |
| 3 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$284K |
| 4 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$9.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$745K |
| 2 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$470K |
| 3 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$259K |
| 4 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
-$97.6K |
| 5 |
Walleye Capital
New York
|
-$70.9K |
NAMSW Hedge Fund Activity: Q1 2024 in Review
11 of the 6,959 institutional investors tracked by Wall St. Rank reported a position in NewAmsterdam Pharma Warrant (NAMSW) for Q1 2024, worth a combined $15.9M — up 181% from $5.65M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of NAMSW and 3 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was GTS Securities, opening a new position worth an estimated $1.1M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $745K sold.
- 11 institutional investors held NewAmsterdam Pharma Warrant (NAMSW) as of Q1 2024, down from 18 in Q4 2023.
- Funds reported $15.9M of NewAmsterdam Pharma Warrant stock for Q1 2024, up 181% quarter-over-quarter.
- 3 funds opened new NewAmsterdam Pharma Warrant positions in Q1 2024 and 10 closed out, a net change of -7 holders.
- The largest NewAmsterdam Pharma Warrant buyer in Q1 2024 was GTS Securities, an estimated $1.1M added.
- The largest NewAmsterdam Pharma Warrant seller in Q1 2024 was EcoR1 Capital, an estimated $745K sold.
Based on aggregated 13F filings for Q1 2024.